BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37048093)

  • 1. Absence of HDAC3 by Matrix Stiffness Promotes Chromatin Remodeling and Fibroblast Activation in Idiopathic Pulmonary Fibrosis.
    Toscano-Marquez F; Romero Y; Espina-Ordoñez M; Cisneros J
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts.
    Nizamoglu M; Alleblas F; Koster T; Borghuis T; Vonk JM; Thomas MJ; White ES; Watson CK; Timens W; El Kasmi KC; Melgert BN; Heijink IH; Burgess JK
    Acta Biomater; 2024 Mar; 177():118-131. PubMed ID: 38350556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
    Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
    Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis.
    Herrera J; Beisang DJ; Peterson M; Forster C; Gilbertsen A; Benyumov A; Smith K; Korenczuk CE; Barocas VH; Guenther K; Hite R; Zhang L; Henke CA; Bitterman PB
    Am J Respir Crit Care Med; 2018 Aug; 198(4):486-496. PubMed ID: 29579397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.
    Korfei M; Mahavadi P; Guenther A
    Cells; 2022 May; 11(10):. PubMed ID: 35626663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.
    Marinković A; Liu F; Tschumperlin DJ
    Am J Respir Cell Mol Biol; 2013 Apr; 48(4):422-30. PubMed ID: 23258227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Fibroblast Mechanotransduction Modulates Severity of Idiopathic Pulmonary Fibrosis.
    Trotsyuk AA; Chen K; Hyung S; Ma KC; Henn D; Mermin-Bunnell AM; Mittal S; Padmanabhan J; Larson MR; Steele SR; Sivaraj D; Bonham CA; Noishiki C; Rodrigues M; Jiang Y; Jing S; Niu S; Chattopadhyay A; Perrault DP; Leeolou MC; Fischer KS; Gurusankar G; Choi Kussie H; Wan DC; Januszyk M; Longaker MT; Gurtner GC
    Adv Wound Care (New Rochelle); 2022 Oct; 11(10):511-523. PubMed ID: 34544267
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
    Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.
    Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
    Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
    Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix abnormalities in pulmonary fibrosis.
    Upagupta C; Shimbori C; Alsilmi R; Kolb M
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29950306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
    Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
    J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Deacetylase 3-Mediated Inhibition of microRNA-19a-3p Facilitates the Development of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Yuan H; Jiao L; Yu N; Duan H; Yu Y; Bai Y
    Front Physiol; 2020; 11():549656. PubMed ID: 33343379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted regulation of fibroblast state by CRISPR-mediated CEBPA expression.
    Liu W; Meridew JA; Aravamudhan A; Ligresti G; Tschumperlin DJ; Tan Q
    Respir Res; 2019 Dec; 20(1):281. PubMed ID: 31829168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic and Epigenetic Profiling of Fibroblasts in Idiopathic Pulmonary Fibrosis.
    Hanmandlu A; Zhu L; Mertens TCJ; Collum S; Bi W; Xiong F; Wang R; Amirthalingam RT; Ren D; Han L; Jyothula SSSK; Li W; Zheng WJ; Karmouty-Quintana H
    Am J Respir Cell Mol Biol; 2022 Jan; 66(1):53-63. PubMed ID: 34370624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
    Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
    Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis.
    Ligresti G; Caporarello N; Meridew JA; Jones DL; Tan Q; Choi KM; Haak AJ; Aravamudhan A; Roden AC; Prakash YS; Lomberk G; Urrutia RA; Tschumperlin DJ
    JCI Insight; 2019 May; 5(12):. PubMed ID: 31095524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.